You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pyrazinamide

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • HIV
  • Port-au-Prince, Haiti
  • +1 more
Nov 11, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • (no location specified)
Jul 7, 2022

Tuberculosis Trial in Cape Town (Meropenem Injection, Amoxicillin Clavulanate, Pyrazinamide)

Completed
  • Tuberculosis
  • Meropenem Injection
  • +4 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jan 24, 2022

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)

Not yet recruiting
  • Tuberculous Meningitis
  • High dose rifampicin (25mg/kg)
  • +8 more
  • Chennai, Tamil Nadu, India
    ICMR- National Institute for Research in Tuberculosis
Jun 15, 2023

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg

Recruiting
  • Tuberculosis, Pulmonary
  • +4 more
  • Johannesburg, South Africa
  • +2 more
Oct 4, 2021

Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)

Completed
Has Results
  • Pulmonary Tuberculosis
  • +2 more
  • (no location specified)
May 23, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Tuberculosis Infection
  • Denver, Colorado
  • +14 more
Mar 2, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Four Months Moxifloxacin Containing Daily Regimen Study Among

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Chennai, Tamilnadu, India
    National Institute for Research in Tuberculosis
Sep 29, 2021

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Tbilisi, Georgia
  • +11 more
Feb 14, 2022

HIV, Tuberculosis Trial in United States (Ethambutol HCl, Isoniazid, Pyrazinamide)

Completed
  • HIV Infections
  • Tuberculosis
  • Ethambutol hydrochloride
  • +5 more
  • Los Angeles, California
  • +11 more
Oct 28, 2021

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

HIV, Tuberculosis Trial in United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • San Francisco, California
  • +24 more
Oct 26, 2021

HIV, Tuberculosis Trial in Puerto Rico, United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • Birmingham, Alabama
  • +75 more
Oct 26, 2021

HIV, Tuberculosis Trial in United States (Cycloserine, Ethionamide, Capreomycin sulfate)

Completed
  • HIV Infections
  • Tuberculosis
  • Chicago, Illinois
  • +20 more
Oct 27, 2021

Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • High-dose rifampicin
  • +4 more
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
Has Results
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

Tuberculosis Trial in Busan, Seoul (Rifampicin, Isoniazid, Pyrazinamide)

Completed
  • Tuberculosis
  • Busan, Korea, Republic of
  • +2 more
Dec 6, 2019

Antiretroviral Drugs and Related Drugs During and After

Completed
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +61 more
Jun 28, 2022

Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant Trial in Worldwide (Moxifloxacin, PA-824,

Completed
Has Results
  • Tuberculosis, Pulmonary, Drug Sensitive
  • Tuberculosis, Pulmonary, Multi Drug-resistant
  • Tbilisi, Georgia
  • +25 more
Mar 1, 2019